Nir Chetrit-Ben

Rehovot, M, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Journal: Oncogene
Published: April 11, 2025

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Journal: Oncogene
Published: February 28, 2024

Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix.

Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix.

Journal: Cancer research
Published: October 14, 2015

EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.

EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.

Journal: Science signaling
Published: March 19, 2015

Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.

Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression.

Journal: EMBO molecular medicine
Published: February 14, 2015

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer.

Journal: Science signaling
Published: January 22, 2015

Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin.

Identification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin.

Journal: Nature communications
Published: April 22, 2014

Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.

Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment.

Journal: Nature communications
Published: March 19, 2014

Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration.

Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration.

Journal: PloS one
Published: June 08, 2013

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 16, 2013

ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.

ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype.

Journal: Cell adhesion & migration
Published: October 19, 2012

Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.

Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.

Journal: Oncogene
Published: December 20, 2011
Showing 1-12 of 14

Last Updated: 09/26/2026